Clinuvel Pharmaceuticals Logo

Clinuvel Pharmaceuticals

🇦🇺
CUV
AU000000CUV3

Clinuvel Pharmaceuticals is a global biopharmaceutical company headquartered in Australia. The firm focuses on the development of innovative drugs for rare skin disorders. Through the application of specialized therapies, Clinuvel improves the quality of life for patients across the globe.

Next Quarterly Earnings

Thursday, August 27, 2026
CW 35
Pre-Market
Today

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Stock Price

Frequently asked questions

When will Clinuvel Pharmaceuticals report its next quarterly earnings?

Clinuvel Pharmaceuticals is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Clinuvel Pharmaceuticals last report quarterly earnings?

Clinuvel Pharmaceuticals last reported quarterly earnings on 2/25/2026 (Q4 2025). Earnings per share (EPS) came in at 0.21 AUD.

How do I add the Clinuvel Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:A$0.46
Actual:
Q4 2025
Missed
Estimate:A$0.30
Actual:A$0.21
Difference:-A$0.09
Price reaction (1 day):-9.3 %
Price reaction (7 days):-8.2 %

Company Information

Name
Clinuvel Pharmaceuticals
Ticker Symbol
CUV
ISIN
AU000000CUV3
Country
🇦🇺
Australia
Sector